Biogen Inc BIIB Secures Felzartamab Rights to Challenge Darzalex Dominance in Chinas Multiple Myeloma Market EOG Resources EOG Upcoming Q1 2026 Earnings Release Signals Upside Potential Amid Favorable Commodity Tailwinds BCSS Bain Cap GSS CEO prioritizes expansion of alternative asset offerings to drive longterm revenue growth MBIO Mustang Bio posts far wider than expected Q4 2024 loss shares dip 123 percent on soft quarterly performance WAT Waters Corporation posts slight Q4 2025 EPS miss shares dip 043 in todays trading session